Details
Stereochemistry | UNKNOWN |
Molecular Formula | C19H25NO4 |
Molecular Weight | 331.4061 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(CC(C)NCC(O)C2=CC(CO)=C(O)C=C2)C=C1
InChI
InChIKey=VPMWDFRZSIMDKW-UHFFFAOYSA-N
InChI=1S/C19H25NO4/c1-13(9-14-3-6-17(24-2)7-4-14)20-11-19(23)15-5-8-18(22)16(10-15)12-21/h3-8,10,13,19-23H,9,11-12H2,1-2H3
Molecular Formula | C19H25NO4 |
Molecular Weight | 331.4061 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Salmefamol is a beta2-adrenoceptor agonist that was studied in asthmatic patients. In clinical trials, the drug had shown marked efficacy with low toxicity and was generally well tolerated. However, information about the further development of salmefamol as a bronchodilator drug is not available.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1173987
Twenty-five asthmatics were tested with salmefamol aerosol (200 mug q.d.s.) for a period of 3 months.
Route of Administration:
Respiratory
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:24:59 GMT 2023
by
admin
on
Sat Dec 16 17:24:59 GMT 2023
|
Record UNII |
Q56SEY8X9J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C48149
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C100251
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
C76547
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
Q56SEY8X9J
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
DTXSID80864864
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
242-662-5
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
86805
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
2883
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107072
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
100000080546
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
18910-65-1
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY | |||
|
SUB10429MIG
Created by
admin on Sat Dec 16 17:24:59 GMT 2023 , Edited by admin on Sat Dec 16 17:24:59 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |